로딩 중…
지수 로딩 중…
Wooree Bio Co.,Ltd
082850· KOSDAQ· Information Technology· Semiconductors & Semiconductor Equipment
₩960+2.35%
2026-08-04
Financials
Valuation Metrics
Wooree Bio Co.,Ltd's Market Cap is ₩465B. At end of 2025 it was ₩986B. Ranked #1788 of 2,436 in KR market (top 73%), #1088 of 1,649 on KOSDAQ (top 66%), #170 of 214 in Semiconductors & Semiconductor Equipment (top 79%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 46.52B KRW | KR#1,788/2,436 Sec#170/214 |
| Revenue | 1.01T KRW | KR#399/2,436 Sec#9/214 |
| Net Income | -9.29B KRW | KR—/2,436 Sec—/214 |
| Total Assets | 868.22B KRW | KR#509/2,436 Sec#19/214 |
| Net Assets | 265.90B KRW | KR#761/2,436 Sec#58/214 |
| Employees | 90 | KR#1,706/2,436 Sec#163/214 |
| Value | ||
| P/B | 0.17x | KR#81/2,436 Sec#4/214 |
| P/S | 0.05x | KR#17/2,436 Sec#1/214 |
| FCF Yield | 27.89% | KR#218/2,436 Sec#6/214 |
| Profitability | ||
| ROE | -3.50% | KR#1,694/2,436 Sec#139/214 |
| ROA | -1.07% | KR#1,606/2,436 Sec#134/214 |
| Op. Margin | -0.41% | KR#1,632/2,436 Sec#134/214 |
| Revenue Growth | -9.76% | KR#1,864/2,436 Sec#158/214 |
| Financial Health | ||
| Debt Ratio | 326.52% | KR#2,185/2,436 Sec#205/214 |
| Total Debt | 246.06B KRW | KR#439/2,436 Sec#20/214 |
| FCF | 12.98B KRW | KR#639/2,436 Sec#49/214 |
| Cash | 0 KRW | KR—/2,436 Sec—/214 |
| Current Ratio | 1.21x | KR#1,563/2,436 Sec#155/214 |
| Dividend | ||
| Div. Yield | 2.13% | KR#864/2,436 Sec#27/214 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/214 |
| Performance | ||
| 1Y Return | -56.95% | KR#2,196/2,436 Sec#207/214 |
| 1M Return | -14.21% | KR#1,994/2,436 Sec#126/214 |
| From 52W High | -64.11% | KR#1,912/2,436 Sec#168/214 |
| 1Y MDD | -65.22% | KR#1,706/2,436 Sec#135/214 |
| Trading | ||
| Volume | 78,700 shares | KR#1,076/2,436 Sec#132/214 |
| Foreign Own. | 6.08% | KR#708/2,436 Sec#76/214 |
| Per Share | ||
| EPS | -138 KRW | KR—/2,436 Sec—/214 |
| BPS | 4,471 KRW | KR#1,534/2,436 Sec#137/214 |
Company Info
동사는 2000년 설립, 2005년 코스닥에 상장되었으며 국내 4개 법인과 중국, 베트남, 미국 등 9개 해외 법인 운영 중임. 건강기능식품, LED PKG, SMT, LED BLU 등의 전자부품을 제조, 판매하며 솔루티오 등 독자 브랜드로 리포좀 공법 적용한 차별화 제품 공급함. FPCB 사업은 신제품 개발, 품질 향상, 원가 경쟁력 강화로 BLU 중심 구조에서 일반산업용 제품으로 확장하고 있음. 우리바이오는 2000년에 설립되었으며 경기도 안산시에 본사를 두고 있습니다.